0

IN THIS ISSUE

Archives of General Psychiatry

February 1992, Vol 49, No. 2
Basic View  |  Expanded View
Instruction s for Authors
Topics:
Arch Gen Psychiatry. 1992;49(2):88. doi:10.1001/archpsyc.1992.01820020008001.
Disability and Depression Among High Utilizers of Health Care:  A Longitudinal Analysis
Michael Von Korff, ScD; Johan Ormel, PhD; Wayne Katon, MD; Elizabeth H. B. Lin, MD, MPH
Topics:
Arch Gen Psychiatry. 1992;49(2):91. doi:10.1001/archpsyc.1992.01820020011002.
Psychiatric Comorbidity in DSM-III-R Hypochondriasis
Arthur J. Barsky, MD; Grace Wyshak, PhD; Gerald L. Klerman, MD
Topics:
Arch Gen Psychiatry. 1992;49(2):101-108. doi:10.1001/archpsyc.1992.01820020021003.
Childhood Parental Loss and Adult Psychopathology in Women:  A Twin Study Perspective
Kenneth S. Kendler, MD; Michael C. Neale, PhD; Ronald C. Kessler, PhD; Andrew C. Heath, DPhil; Lindon J. Eaves, PhD, DSc
Topics:
Arch Gen Psychiatry. 1992;49(2):109-116. doi:10.1001/archpsyc.1992.01820020029004.
Major Depression in a Nonclinical Sample:  Demographic and Clinical Risk Factors for First Onset
William Coryell, MD; Jean Endicott, PhD; Martin Keller, MD
Topics:
Arch Gen Psychiatry. 1992;49(2):117-125. doi:10.1001/archpsyc.1992.01820020037005.
Rapidly Cycling Affective Disorder:  Demographics, Diagnosis, Family History, and Course
William Coryell, MD; Jean Endicott, PhD; Martin Keller, MD
Topics:
Arch Gen Psychiatry. 1992;49(2):126-131. doi:10.1001/archpsyc.1992.01820020046006.
Low Serotonin and Dopamine Metabolite Concentrations in Cerebrospinal Fluid From Bulimic Patients With Frequent Binge Episodes
David C. Jimerson, MD; Michael D. Lesem, MD; Walter H. Kaye, MD; Timothy D. Brewerton, MD
Topics:
Arch Gen Psychiatry. 1992;49(2):132-138. doi:10.1001/archpsyc.1992.01820020052007.
Fluoxetine in the Treatment of Bulimia Nervosa:  A Multicenter, Placebo-Controlled, Double-blind Trial
Topics:
Arch Gen Psychiatry. 1992;49(2):139-147. doi:10.1001/archpsyc.1992.01820020059008.
Psychiatric, Genetic, and Positron Emission Tomographic Evaluation of Persons at Risk for Huntington's Disease
Lewis R. Baxter, MD; John C. Mazziotta, MD, PhD; Jorg J. Pahl, MD; Scott T. Grafton, MD; Peter St. George-Hyslop, MD; Jonathan L. Haines, PhD; James F. Gusella, PhD; Martin P. Szuba, MD; Carl E. Selin, MS; Barry H. Guze, MD; Michael E. Phelps, PhD
Topics:
Arch Gen Psychiatry. 1992;49(2):148-154. doi:10.1001/archpsyc.1992.01820020068009.
Current Excitement With D2 Dopamine Receptor Gene Alleles in Substance Abuse
George R. Uhl, MD, PHD; Antonio M. Persico, MD; Stevens S. Smith, PhD
Topics:
Arch Gen Psychiatry. 1992;49(2):157-160. doi:10.1001/archpsyc.1992.01820020068010.
Effect of Buspirone on Prolactin Secretion Is Not Mediated by 5-HT-1a Receptor Stimulation
Herbert Y. Meltzer, MD; Shick Lee Hong, MD; J. Frank Nash, PhD
Topics:
Arch Gen Psychiatry. 1992;49(2):163. doi:10.1001/archpsyc.1992.01820020083011.
Effect of Buspirone on Prolactin Secretion Is Not Mediated by 5-HT-1a Receptor Stimulation-Reply
Emil F. Coccaro, MD; Steven Garbriel, PhD; Theresa Mahon, PhD; Joseph Macaluso, MD; Larry J. Siever, MD
Topics:
Arch Gen Psychiatry. 1992;49(2):163-164. doi:10.1001/archpsyc.1992.01820020083012.
Blacks, Schizophrenia, and Neuroleptic Treatment
A. McLeod-Bryant Stephen, MD
Topics:
Arch Gen Psychiatry. 1992;49(2):164-165. doi:10.1001/archpsyc.1992.01820020084013.
Blacks, Schizophrenia, and Neuroleptic Treatment-Reply
F. Levinson Douglas, MD; M. Simpson George, MD
Topics:
Arch Gen Psychiatry. 1992;49(2):165. doi:10.1001/archpsyc.1992.01820020085014.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems